Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Alzheimer and vascular brain disease: Senile dementia.

Engelhardt E, Grinberg LT.

Dement Neuropsychol. 2015 Apr-Jun;9(2):184-188. doi: 10.1590/1980-57642015DN92000013.

2.

Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease: A Systematic Review.

Sarica A, Cerasa A, Quattrone A.

Front Aging Neurosci. 2017 Oct 6;9:329. doi: 10.3389/fnagi.2017.00329. eCollection 2017. Review.

3.

Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation.

Ahmad W, Ijaz B, Shabbiri K, Ahmed F, Rehman S.

J Biomed Sci. 2017 Sep 19;24(1):76. doi: 10.1186/s12929-017-0379-z. Review.

4.

Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.

Son SJ, Kim J, Park H.

PLoS One. 2017 Mar 23;12(3):e0173426. doi: 10.1371/journal.pone.0173426. eCollection 2017.

5.

Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging.

Coder B, Wang W, Wang L, Wu Z, Zhuge Q, Su DM.

Oncotarget. 2017 Jan 24;8(4):7116-7137. doi: 10.18632/oncotarget.12572. Review. Erratum in: Oncotarget. 2017 Aug 7;8(32):53887.

6.

Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns.

Zhang W, Jiao B, Zhou M, Zhou T, Shen L.

Stem Cells Int. 2016;2016:7828049. doi: 10.1155/2016/7828049. Epub 2016 May 24. Review.

7.

Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.

Green C, Zhang S.

Alzheimers Dement. 2016 Jul;12(7):776-85. doi: 10.1016/j.jalz.2016.01.011. Epub 2016 Mar 24.

8.

A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.

Pérez-Hernández J, Zaldívar-Machorro VJ, Villanueva-Porras D, Vega-Ávila E, Chavarría A.

Oxid Med Cell Longev. 2016;2016:8378613. doi: 10.1155/2016/8378613. Epub 2016 Jan 6. Review.

9.

Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.

Földes A, Kádár K, Kerémi B, Zsembery Á, Gyires K, S Zádori Z, Varga G.

Curr Neuropharmacol. 2016;14(8):914-934. Review.

10.

Heme oxygenase effect on mesenchymal stem cells action on experimental Alzheimer's disease.

Abdel Aziza MT, Atta HM, Samer H, Ahmed HH, Rashed LA, Sabry D, Abdel Raouf ER, Alkaffas MA.

EXCLI J. 2013 Sep 3;12:778-92. eCollection 2013.

11.

The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis.

Liu S, Zeng F, Wang C, Chen Z, Zhao B, Li K.

Sci Rep. 2015 Sep 4;5:13598. doi: 10.1038/srep13598.

12.

Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.

Ye T, Zu C, Jie B, Shen D, Zhang D; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2016 Sep;10(3):739-49. doi: 10.1007/s11682-015-9437-x.

13.

Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease.

Jiang N, Leithold LH, Post J, Ziehm T, Mauler J, Gremer L, Cremer M, Schartmann E, Shah NJ, Kutzsche J, Langen KJ, Breitkreutz J, Willbold D, Willuweit A.

PLoS One. 2015 Jun 5;10(6):e0128553. doi: 10.1371/journal.pone.0128553. eCollection 2015.

14.

Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease.

Miklossy J.

Front Aging Neurosci. 2015 Apr 16;7:46. doi: 10.3389/fnagi.2015.00046. eCollection 2015. Review.

15.

Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers.

Kim YH, Choi HY, Lim HS, Lee SH, Jeon HS, Hong D, Kim SS, Choi YK, Bae KS.

Drug Des Devel Ther. 2015 Mar 10;9:1419-26. doi: 10.2147/DDDT.S78555. eCollection 2015.

16.

Treatment of Alzheimer's disease in Iranian traditional medicine.

Ahmadian-Attari MM, Ahmadiani A, Kamalinejad M, Dargahi L, Shirzad M, Mosaddegh M.

Iran Red Crescent Med J. 2014 Dec 25;17(1):e18052. doi: 10.5812/ircmj.18052. eCollection 2015 Jan.

17.

Alzheimer disease immunotherapeutics: then and now.

Jindal H, Bhatt B, Sk S, Singh Malik J.

Hum Vaccin Immunother. 2014;10(9):2741-3. doi: 10.4161/21645515.2014.970959. Epub 2014 Oct 31. Review.

18.

Alzheimer's disease and prion protein.

Zhou J, Liu B.

Intractable Rare Dis Res. 2013 May;2(2):35-44. doi: 10.5582/irdr.2013.v2.2.35. Review.

19.

Frequent and discriminative subnetwork mining for mild cognitive impairment classification.

Fei F, Jie B, Zhang D.

Brain Connect. 2014 Jun;4(5):347-60. doi: 10.1089/brain.2013.0214.

20.

Tau-induced neurodegeneration: mechanisms and targets.

Beharry C, Cohen LS, Di J, Ibrahim K, Briffa-Mirabella S, Alonso Adel C.

Neurosci Bull. 2014 Apr;30(2):346-58. doi: 10.1007/s12264-013-1414-z. Epub 2014 Apr 15. Review.

Supplemental Content

Support Center